Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2006 1
2007 2
2008 8
2009 8
2010 5
2011 6
2012 8
2013 12
2014 8
2015 8
2016 11
2017 12
2018 10
2019 8
2020 12
2021 12
2022 27
2023 22
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial.
Manuel O, Laager M, Hirzel C, Neofytos D, Walti LN, Hoenger G, Binet I, Schnyder A, Stampf S, Koller M, Mombelli M, Kim MJ, Hoffmann M, Koenig K, Hess C, Burgener AV, Cippà PE, Hübel K, Mueller TF, Sidler D, Dahdal S, Suter-Riniker F, Villard J, Zbinden A, Pantaleo G, Semmo N, Hadaya K, Enríquez N, Meylan PR, Froissart M, Golshayan D, Fehr T, Huynh-Do U, Pascual M, van Delden C, Hirsch HH, Jüni P, Mueller NJ; Swiss Transplant Cohort Study (STCS). Manuel O, et al. Clin Infect Dis. 2024 Feb 17;78(2):312-323. doi: 10.1093/cid/ciad575. Clin Infect Dis. 2024. PMID: 37738676 Free PMC article. Clinical Trial.
Prognostic models in COVID-19 infection that predict severity: a systematic review.
Buttia C, Llanaj E, Raeisi-Dehkordi H, Kastrati L, Amiri M, Meçani R, Taneri PE, Ochoa SAG, Raguindin PF, Wehrli F, Khatami F, Espínola OP, Rojas LZ, de Mortanges AP, Macharia-Nimietz EF, Alijla F, Minder B, Leichtle AB, Lüthi N, Ehrhard S, Que YA, Fernandes LK, Hautz W, Muka T. Buttia C, et al. Among authors: leichtle ab. Eur J Epidemiol. 2023 Apr;38(4):355-372. doi: 10.1007/s10654-023-00973-x. Epub 2023 Feb 25. Eur J Epidemiol. 2023. PMID: 36840867 Free PMC article. Review.
Endocrinological and inflammatory markers in individuals with spinal cord injury: A systematic review and meta-analysis.
Boehl G, Raguindin PF, Valido E, Bertolo A, Itodo OA, Minder B, Lampart P, Scheel-Sailer A, Leichtle A, Glisic M, Stoyanov J. Boehl G, et al. Among authors: leichtle a. Rev Endocr Metab Disord. 2022 Oct;23(5):1035-1050. doi: 10.1007/s11154-022-09742-9. Epub 2022 Aug 18. Rev Endocr Metab Disord. 2022. PMID: 35978214 Free PMC article. Review.
[Immunomodulation in Cholesteatoma].
Leichtle A, Leffers D, Daerr MG, Draf C, Kurabi A, Ryan AF, Rupp J, Bruchhage KL. Leichtle A, et al. Laryngorhinootologie. 2022 Apr;101(4):310-319. doi: 10.1055/a-1516-4447. Epub 2021 Jul 7. Laryngorhinootologie. 2022. PMID: 34233375 German.
Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.
Walti LN, Mugglin C, Mombelli M, Manuel O, Hirsch HH, Khanna N, Mueller NJ, Berger C, Boggian K, Garzoni C, Neofytos D, van Delden C, Mäusezahl M, Hirzel C; Swiss Transplant Cohort Study. Walti LN, et al. JAMA Netw Open. 2023 Apr 3;6(4):e2310687. doi: 10.1001/jamanetworkopen.2023.10687. JAMA Netw Open. 2023. PMID: 37115546 Free PMC article.
TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC.
von Bernuth A, Ribbat-Idel J, Klapper L, Jagomast T, Rades D, Leichtle A, Pries R, Bruchhage KL, Perner S, Offermann A, Sailer V, Idel C. von Bernuth A, et al. Among authors: leichtle a. Int J Mol Sci. 2023 Mar 7;24(6):5140. doi: 10.3390/ijms24065140. Int J Mol Sci. 2023. PMID: 36982215 Free PMC article.
Immunomodulation as a Protective Strategy in Chronic Otitis Media.
Leichtle A, Kurabi A, Leffers D, Därr M, Draf CS, Ryan AF, Bruchhage KL. Leichtle A, et al. Front Cell Infect Microbiol. 2022 Mar 30;12:826192. doi: 10.3389/fcimb.2022.826192. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35433505 Free PMC article.
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2).
Griessbach A, Chammartin F, Abela IA, Amico P, Stoeckle MP, Eichenberger AL, Hasse B, Braun DL, Schuurmans MM, Müller TF, Tamm M, Audigé A, Mueller NJ, Rauch A, Günthard HF, Koller MT, Trkola A, Epp S, Amstutz A, Schönenberger CM, Taji Heravi A, Kusejko K, Bucher HC, Briel M, Speich B; Swiss HIV Cohort Study and the Swiss Transplant Cohort Study. Griessbach A, et al. Open Forum Infect Dis. 2023 Mar 30;10(4):ofad150. doi: 10.1093/ofid/ofad150. eCollection 2023 Apr. Open Forum Infect Dis. 2023. PMID: 37035486 Free PMC article.
167 results